INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,187 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
36
WM
Winter Charles M.Chief Technical Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$33K
2,401 sh
Jan 2, 2026Jan 2, 2026
Page 1585 of 1855
← PrevNext →
traded Jan 2, 2026
+0d
SEC Form 4

Evidence

32
MH
Meyer Andrew HollmanChief Business Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$26K
1,879 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

30
YS
Yoon SungSVP
KEYSKeysight Technologies, Inc.
Open-market sale
SELL$184K
889 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

29
CH
Carson William H.Director
ANNXAnnexon, Inc.
Open-market purchase · 10b5-1 plan
BUY$21K
4,115 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

28
BO
Blunt Christopher ODirector, Chief Executive Officer
FGF&G Annuities & Life, Inc.
Open-market purchase
BUY$148K
5,000 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

27
BE
Butler ErinPrincipal Accounting Officer
IMAImageneBio, Inc.
Grant or award
A—
22.5K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

27
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

27
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

27
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$620K
8,089 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

27
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

26
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$2.80M
632.9K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

24
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$2.77M
632.9K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

23
MD
Metzfield DennisVP, PAO & Controller
BAHBooz Allen Hamilton Holding Corp
Grant or award
A—
1,175 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

23
SJ
Sahasi JayeshEV President, Product and CTO
ONTFON24 INC.
Open-market sale · 10b5-1 plan
SELL$277K
34.8K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

22
MD
Maday DavidChief Financial Officer
AURAurora Innovation, Inc.
Gift
G—
79.9K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

22
OW
Owens Donald WDirector, CEO, President and Secretary, 10% Owner
HNOIHNO International, Inc.
Gift
G—
450.0K sh
Nov 26, 2025Jan 2, 2026
traded Nov 26, 2025
+37dSEC Form 4

Evidence

21
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

21
RS
Ravella SatishChief Accounting Officer
ZETAZeta Global Holdings Corp.
Grant or award
A—
100.0K sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

21
SH
Schatz Britta HarrisDirector
DGICADONEGAL GROUP INC
Grant or award
A$24K
1,200 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
MZ
McIver ZachariahChief Medical Officer
JANXJanux Therapeutics, Inc.
Grant or award
A—
29.0K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
BN
Ballew NealCHIEF ACCOUNTING OFFICER
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
15.4K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

21
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

21
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

21
GP
Gourmand Matthew PaulPresident
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
15.4K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

21
DN
Doyle Janeen NoelChief Corp. & Bus. Dev. Ofcr
JANXJanux Therapeutics, Inc.
Grant or award
A—
36.0K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
DM
Dobek MariaVice President, Accounting
JANXJanux Therapeutics, Inc.
Grant or award
A—
18.9K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

21
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

20
BJ
Blackie JamesChief Revenue Officer
ONTFON24 INC.
Open-market sale · 10b5-1 plan
SELL$127K
16.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

20
MM
Morral Peter M.Chief Development Officer
GPMTGranite Point Mortgage Trust Inc.
Tax withholding
F$74K
30.7K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

19
SS
Smith Maurice SDirector
HALHALLIBURTON CO
Grant or award
A—
1,212 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

19
SC
Shackley Brian CharlesChief Accounting Officer
AVAVAeroVironment Inc
Open-market sale · 10b5-1 plan
SELL$50K
200 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

19
MR
Mills Jason RichardDirector
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Grant or award
A—
7,758 sh
Dec 18, 2025Jan 2, 2026
traded Dec 18, 2025
+15dSEC Form 4

Evidence

19
MR
Mills Jason RichardDirector
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Grant or award
A—
4,806 sh
Dec 18, 2025Jan 2, 2026
traded Dec 18, 2025
+15dSEC Form 4

Evidence

18
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

18
TB
Thompson Steve BPrimeLending President and CEO
HTHHilltop Holdings Inc.
Tax withholding
F$84K
2,468 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

18
MD
Maday DavidChief Financial Officer
AURAurora Innovation, Inc.
Gift
G—
79.9K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

18
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

18
CJ
Cmil JenniferEVP and Chief People Officer
NEMNEWMONT Corp /DE/
Tax withholding
F$67K
609 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence